Quantitation of biperiden in whole blood by MALDI-QTOF tandem mass spectrometry, and estimation of new metabolites in urine of deceased subjects treated with biperiden antemortem

In this work, the application of matrix-assisted laser desorption ionization (MALDI)-quadrupole time-of-flight (QTOF)-tandem mass spectrometry (MS/MS) to the quantitation of the anticholinergic/antiparkinson drug biperiden in human whole blood, and the estimation of new phase I metabolites of biperi...

Full description

Saved in:
Bibliographic Details
Published inForensic toxicology Vol. 35; no. 1; pp. 86 - 93
Main Authors Minakata, Kayoko, Yamagishi, Itaru, Nozawa, Hideki, Hasegawa, Koutaro, Suzuki, Masako, Gonmori, Kunio, Suzuki, Osamu, Watanabe, Kanako
Format Journal Article
LanguageEnglish
Published Tokyo Springer Japan 01.01.2017
Subjects
Online AccessGet full text
ISSN1860-8965
1860-8973
DOI10.1007/s11419-016-0341-x

Cover

More Information
Summary:In this work, the application of matrix-assisted laser desorption ionization (MALDI)-quadrupole time-of-flight (QTOF)-tandem mass spectrometry (MS/MS) to the quantitation of the anticholinergic/antiparkinson drug biperiden in human whole blood, and the estimation of new phase I metabolites of biperiden in human urine, were performed for the first time. The limit of detection of biperiden in human whole blood was 0.3 ng/mL with a quantitation range of 1–100 ng/mL using 20 μL each of whole blood. The developed method was successfully applied to the determination of biperiden in whole blood obtained from two deceased subjects having a history of biperiden treatment. The concentrations of biperiden in the whole blood samples were 1.7 and 17.5 ng/mL. The MALDI-QTOF-MS/MS method was also used to estimate the metabolites of biperiden in urine obtained from the subjects. Six new metabolites formed by hydroxylation and/or dehydration were detected.
ISSN:1860-8965
1860-8973
DOI:10.1007/s11419-016-0341-x